Wollaston-Hayden EE, Harris RBS, Liu B, Bridger R, Xu Y, Wells L
Use of GLP-1 analogue drugs is associated with benefits but also health risks The use of glucagon-like peptide-1 receptor agonists (GLP-1RAs), used to treat diabetes and obesity, may be associated with a wide range of health effects, both positive - such as a reduced risk of cardiometabolic disorders - and negative - an increased risk of gastrointestinal conditions or hypertension
Dexpanthenol (0.3%) : Also known as Pro-Vitamin B5, it soothes, hydrates, and supports skin barrier repair
The reasons for problems with the translation of experimental results include limited penetration through the BBB, specific differences in pharmacokinetics, and variability in response to treatment due to genetic and metabolic factors